Out-of-pocket costs from diagnostic testing after prostate cancer screening are common and rising

FHS
July 15, 2024
4:59 pm

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) diagnostic testing to establish a diagnosis.

What’s in Kamala Harris’ Medical History?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

October 20, 2024

Lawsuit alleges Biogen schemed with PBMs to preserve Tecfidera market

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 21, 2024

NIH scientists uncover brain circuitry behind face detection in primates

Scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in primates that rapidly detects faces.

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.